Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study

BACKGROUND: China implemented the national drug price negotiation (NDPN) policy to include 17 innovative anticancer medicines in the national reimbursement drug list in 2018. We aimed to assess the impact of this policy on the utilization, cost, and accessibility of anticancer medicines. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Lele, Tao, Tiantian, Li, Hongtao, Zhang, Zhuolin, Zhang, Lingli, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2022
Materias:
Research Theme 7: Health Transitions in China
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758701/
https://www.ncbi.nlm.nih.gov/pubmed/36527382
http://dx.doi.org/10.7189/jogh.12.11016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758701/
https://www.ncbi.nlm.nih.gov/pubmed/36527382
http://dx.doi.org/10.7189/jogh.12.11016

Ejemplares similares